Alterity Therapeutics Statistics
Total Valuation
ATHE has a market cap or net worth of $81.15 million. The enterprise value is $54.51 million.
| Market Cap | 81.15M |
| Enterprise Value | 54.51M |
Important Dates
The next estimated earnings date is Monday, August 31, 2026.
| Earnings Date | Aug 31, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ATHE has 217.51 million shares outstanding. The number of shares has increased by 74.72% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 217.51M |
| Shares Change (YoY) | +74.72% |
| Shares Change (QoQ) | +36.08% |
| Owned by Insiders (%) | 3.32% |
| Owned by Institutions (%) | 34.10% |
| Float | 172.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 22.02 |
| Forward PS | 39.15 |
| PB Ratio | 2.75 |
| P/TBV Ratio | 2.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 14.79 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.52, with a Debt / Equity ratio of 0.00.
| Current Ratio | 14.52 |
| Quick Ratio | 14.26 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -54.98% and return on invested capital (ROIC) is -34.19%.
| Return on Equity (ROE) | -54.98% |
| Return on Assets (ROA) | -31.75% |
| Return on Invested Capital (ROIC) | -34.19% |
| Return on Capital Employed (ROCE) | -54.54% |
| Weighted Average Cost of Capital (WACC) | 4.05% |
| Revenue Per Employee | $409,445 |
| Profits Per Employee | -$1.80M |
| Employee Count | 9 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ATHE has paid $78,519 in taxes.
| Income Tax | 78,519 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.80% in the last 52 weeks. The beta is -0.04, so ATHE's price volatility has been lower than the market average.
| Beta (5Y) | -0.04 |
| 52-Week Price Change | -9.80% |
| 50-Day Moving Average | 4.84 |
| 200-Day Moving Average | 3.98 |
| Relative Strength Index (RSI) | 46.76 |
| Average Volume (20 Days) | 16,120 |
Short Selling Information
The latest short interest is 24,763, so 0.14% of the outstanding shares have been sold short.
| Short Interest | 24,763 |
| Short Previous Month | 21,094 |
| Short % of Shares Out | 0.14% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.33 |
Income Statement
In the last 12 months, ATHE had revenue of $3.69 million and -$16.19 million in losses. Loss per share was -$0.08.
| Revenue | 3.69M |
| Gross Profit | 3.50M |
| Operating Income | -16.17M |
| Pretax Income | -16.11M |
| Net Income | -16.19M |
| EBITDA | -16.17M |
| EBIT | -16.17M |
| Loss Per Share | -$0.08 |
Balance Sheet
The company has $25.82 million in cash and $133,840 in debt, with a net cash position of $25.68 million or $0.12 per share.
| Cash & Cash Equivalents | 25.82M |
| Total Debt | 133,840 |
| Net Cash | 25.68M |
| Net Cash Per Share | $0.12 |
| Equity (Book Value) | 29.56M |
| Book Value Per Share | 0.14 |
| Working Capital | 29.52M |
Cash Flow
| Operating Cash Flow | -9.83M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 9,726 |
| Net Borrowing | -89,656 |
| Free Cash Flow | -9.83M |
| FCF Per Share | -$0.05 |
Margins
| Gross Margin | 95.07% |
| Operating Margin | -438.88% |
| Pretax Margin | -437.19% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ATHE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -74.72% |
| Shareholder Yield | -74.72% |
| Earnings Yield | -19.95% |
| FCF Yield | -12.11% |
Analyst Forecast
The average price target for ATHE is $13.25, which is 193.79% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.25 |
| Price Target Difference | 193.79% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | -15.28% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 9, 2023. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jan 9, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |